With great power comes great responsibility. . . . The role of pharmacists in ensuring health equity

Paes D. On advancing health equity. 2025. Available: https://www.pharmacists.ca/pharmacy-in-canada/cpo-conversations/on-advancing-health-equity/ (accessed Jul. 9, 2025).

World Health Organization. Health equity. 2025. Available: https://www.who.int/health-topics/health-equity#tab=tab_1 (accessed Jul. 4, 2025).

Government of Canada. Social determinants of health and health inequalities. 2024. Available: https://www.canada.ca/en/public-health/services/health-promotion/population-health/what-determines-health.html (accessed Jul. 4, 2025).

Royal Pharmaceutical Society. Tackling health inequalities: delivering accessible pharmaceutical care for everyone. 2023. Available: https://www.rpharms.com/Portals/0/RPS%20Tackling%20Health%20Inequalities.pdf (accessed Jul. 4, 2025).

Raphael D. Social determinants of health: a Canadian perspective. 4th ed. Toronto (Ontario): Canadian Scholars’ Press; 2025.

Keays D Hajizadeh M. Determinants of socioeconomic inequalities in well-being in Canada: evidence from the Nova Scotia Quality of Life Survey. Int J Health Policy Manag 2025;14:8643. doi:10.34172/ijhpm.8643

Santos Salas A LeGuerrier B Horvath L , et al. The impact of socioeconomic inequality on access to health care for patients with advanced cancer: a qualitative study. Asia Pac J Oncol Nurs 2024;11(7):100520. doi:10.1016/j.apjon.2024.100520

Gillespie J. Health disparities for Canada’s remote and northern residents: can COVID-19 help level the field? J Bioeth Inq 2023;20(2):207-13. doi:10.1007/s11673-023-10245-8

Green M. Action still needed on health disparities affecting rural and remote communities. Can Fam Physician 2024;70(9):597. doi:10.46747/cfp.7009597

Alberta College of Pharmacists. Standards of practice for pharmacists and pharmacy technicians. 2025. Available: https://abpharmacy.ca/wp-content/uploads/Standards_SPPPT.pdf (accessed Jul. 7, 2025).

Reinold J Kollhorst B Wentzell N Platzbecker K Haug U. Use of isotretinoin among girls and women of childbearing age and occurrence of isotretinoin-exposed pregnancies in Germany: a population-based study. PLoS Med 2024;21(1):e1004339. doi:10.1371/journal.pmed.1004339

Liu S Tsuyuki RT Graham MM Nelson D Semeniuk G Al Hamarneh YN . Implementation of Pharmacist Case-Finding and Care Pathway Intervention for Vascular Prevention (PRxOACT): protocol for a randomized controlled trial. CJC Open 2025;7(6):821-831.

Shiu JR Simpson SH Johnson JA. Quantifying opportunities to affect diabetes management in the community. Can Pharm J 2006;139:37.

Tsuyuki RT Beahm NP Okada H Al Hamarneh YN. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J (Ott) 2018;151(1):4-5. doi:10.1177/1715163517745517

Al Hamarneh YN . Economic evidence for pharmacist prescribing in community pharmacy. In: Babar Z , ed. Encyclopedia of evidence in pharmaceutical public health and health services research in pharmacy. Cham (Switzerland): Springer; 2023:1-12. doi:10.1007/978-3-030-50247-8_69-1

Al Hamarneh YN Charrois T Lewanczuk R Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open 2013;3(9):e003154.

Al Hamarneh YN Johnston K Marra CA Tsuyuki RT. Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study. Can Pharm J (Ott) 2019;152(4):257-66.

Al Hamarneh YN Okada H Tsuyuki RT. Real-world implementation of diabetes management by pharmacists: the RXING practice tool. Can Pharm J (Ott) 2021;154(3):160-5.

Al Harmarneh YN Lamb S Donald M , et al. Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study. Can Pharm J (Ott) 2018;151(4):223-7.

Tsuyuki RT Al Hamarneh YN Jones CA Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol 2016;67(24):2846-54.

Tsuyuki RT Houle SK Charrois TL , et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Circulation 2015;132(2):93-100.

Canadian Institute for Health Information. Internationally educated health professionals. 2024. Available: https://www.cihi.ca/en/the-state-of-the-health-workforce-in-canada-2022/internationally-educated-health-professionals (accessed Jul. 9, 2025).

Osasu Y. The role of community pharmacy in addressing health inequalities. The Pharma J 2024;312(7983):1-17. doi:10.1211/PJ.2024.1.300234

Kwan N. Pharmacists’ role in expanding healthcare equity. US Pharm 2024;49(8):41-5. Available: https://www.uspharmacist.com/article/pharmacists-role-in-expanding-healthcare-equity (accessed Jul. 8, 2025).

Rothwell M Carlisle K Cairns A Wallace V McDermott K. Pharmacy practice and First Peoples health equity: a scoping review. Res Social Adm Pharm. Published online June 18, 2025. doi:10.1016/j.sapharm.2025.06.105

Hunter E. The community pharmacy can leverage trust to improve health equity outcomes. Pharmacy Times. 2023. Available: https://www.pharmacytimes.com/view/the-community-pharmacy-can-leverage-trust-to-improve-health-equity-outcomes (accessed Jul. 8, 2025).

Hunter E. Community pharmacy can help solve health equity challenges in clinical research. Pharmacy Times. 2024. Available: https://www.pharmacytimes.com/view/community-pharmacy-can-help-solve-health-equity-challenges-in-clinical-research (accessed Jul. 8, 2025).

Maximos M Greaves L Ng K , et al. Bridging gaps in Canadian health research: the critical role of sex, gender, and equity in shaping inclusive and evidence-informed health care. Can Pharm J (Ott). Published online July 2025. doi:10.1177/17151635251353232

Urslak R Dao T. Full scope of practice is vital for rural health care: student experience in Peace River. Can Pharm J (Ott) 2023;156(3):112-4. doi:10.1177/17151635231169606

Suri A Quinn J Balise RR Feaster DJ El-Bassel N Rundle AG. Disadvantaged groups have greater spatial access to pharmacies in New York state. BMC Health Serv Res 2024;24:471. doi:10.1186/s12913-024-10901-8

Liberty L. Pharmacy practice in rural and remote areas of Canada. 2023. Available: https://www.cshp.ca/Site/Site/Content/News/news-items/resource-spotlight-rural-remote-pharm.aspx (accessed Jul. 9, 2025).

Lamb A. Community is medicine: first-ever gathering of Indigenous Pharmacy Professionals of Canada. Can Phar J (Ott) 2024;157:13-16.

Pirlot M Swidrovich J. Two-Spirit Peoples’ experiences accessing and receiving care from community pharmacies. Can Pharm J (Ott) 2024;157:341-6.

Swidrovich J Tsuyuki RT. Laying the groundwork for decolonization, Indigenization and reconciliation in pharmacy. Can Pharm J 2023;156:108-9.

Swidrovich J. Tensions between Western and Indigenous worldviews in pharmacy education and practice: Part I. Can Pharm J 2023;156:177-81.

Swidrovich J. Tensions between Western and Indigenous worldviews in pharmacy education and practice: Part II. Can Pharm J 2023;156:235-9.

Swidrovich J. Tensions between Western and Indigenous worldviews in pharmacy education and practice: Part III. Can Pharm J 2023;156:293-5.

Vishembera M. Equity, diversity, inclusion, and Indigenous training for pharmacy professionals. Can Pharm J (Ott) 2025;158:73-4.

Timony P Leone A Caron C , et al. Reporting on knowledge, attitudes, and behaviours of pharmacists regarding the active offer of French language health services in Ontario: a quantitative survey study. Can Pharm J (Ott) 2025;158:161-71.

Lim T Tsai M Reyes A Kapanen A D’Amato F. Deaf, deaf-blind, and hard of hearing needs and perceptions of community pharmacy services. Can Pharm J (Ott) 2025;158:90-7.

Suzuki S Nishikawa Y Nakayama T Okada H. Pharmacist accessibility for non-native Japanese speakers: a cross-sectional study in Japan. Can Pharm J (Ott) 2025;158:140-9.

Morrison B Boyle TA Johnson S. Lost in translation: assessing the readability of online information on community pharmacy services. Can Pharm J (Ott) 2025;158:227-35.

Booker C Murphy AL Isenor JE , et al. Community pharmacists’ acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Can Pharm J (Ott) 2023;156:137-49.

MacDonald CB Murphy AL Isenor JE , et al. Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Can Pharm J (Ott) 2023;156:194-203.

Tkachuk S Ready E Chan S , et al. Role of the pharmacist caring for people at risk of or living with HIV in Canada. Can Pharm J (Ott) 2024;157:218-39.

Gebre A Bowles S Minard LV Hamilton-Hinch B Borden N. Understanding the experiences of Black Nova Scotians with community pharmacists. Can Pharm J (Ott) 2023;156:316-23.

Tsuyuki RT. Pharmacists provide exceptional patient-centred care (but what if you’re Black?). Can Pharm J (Ott) 2023;156(6):290-2.

Nemeroff S Gupta N Miah P. The gender wage gap in the Canadian pharmacy workforce in the wake of COVID-19. Can Pharm J (Ott) 2025;158:219-26.

Grootendorst JP Kralj B Sweetman A. Long-term trends in the labour supply and productivity of pharmacists in Canada. Can Pharm J (Ott) 2025;158:236-46.

Hussein T Cartright N Kirschner J Nadarasa A Rathbone AP Lindsey L. Social prescribing in pharmacies: what is it, does it work and what does it mean for Canadian pharmacies? Can Pharm J (Ott) 2024;157:21-4.

Steenhof N Ng K. Buprenorphine-naloxone in chronic pain: overcoming stigma for safer opioid management. Can Pharm J (Ott) 2024;157:7-9.

Watson KE Tsuyuki RT Dixon DL Liu S Al Hamarneh YN. Accessibility reality check. Can Pharm J (Ott) 2024;157:155-60.